Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the antitumor effects and safety of bendamustine
hydrochloride (SyB L-0501) in patients with indolent B-cell non-Hodgkin's lymphoma or mantle
cell lymphoma.